- Home
- CTVA
CTVA
Corteva Inc.
as 12-18-2024 4:00pm EST
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | INDIANAPOLIS |
| Market Cap: | 44.1B | IPO Year: | N/A |
| Target Price: | $65.00 | AVG Volume (30 days): | 3.6M |
| Analyst Decision: | Buy | Number of Analysts: | 18 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.98 | EPS Growth: | -24.52 |
| 52 Week Low/High: | $44.01 - $64.20 | Next Earning Date: | 02-05-2025 |
| Revenue: | $16,637,000,000 | Revenue Growth: | -4.08% |
| Revenue Growth (this year): | 0.62% | Revenue Growth (next year): | 2.33% |
Latest Corteva Inc. News
CTVA Breaking Stock News: Dive into CTVA Ticker-Specific Updates for Smart Investing
Simply Wall St.
10 hours ago
Calculating The Intrinsic Value Of Corteva, Inc. (NYSE:CTVA)
MT Newswires
a day ago
BMO Capital Raises Corteva Price Target to $70 From $67, Maintains Outperform Rating
MT Newswires
2 days ago
Jefferies Adjusts Corteva Price Target to $74 From $67, Maintains Buy Rating
PR Newswire
8 days ago
Corteva Announces Dates for Fourth Quarter 2024 Earnings Release and Webcast
Zacks
9 days ago
Arcadia Biosciences to Merge With Roosevelt, Shares Surge 105%
Bloomberg
13 days ago
Corteva Eyes Brazil to Boost Sales of US-Dominating Soybeans
The Wall Street Journal
13 days ago
UnitedHealth Shooting Is a Wake-Up Call on Corporate Security
MT Newswires
13 days ago
UBS Adjusts Price Target on Corteva to $74 From $71, Keeps Buy Rating
Compare CTVA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CTVA Corteva Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.